observation on the therapeutic effect of aspirin in combined with ozagrel sodium in the treatment of acute cerebral infarction
Clicks: 215
ID: 202142
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
214 views
26 readers
Trending
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objective: To explore the clinical efficacy of aspirin in combined with ozagrel sodium in
the treatment of acute cerebral infarction (ACI). Methods: A total of 120 patients with ACI
who were admitted in our hospital from May, 2015 to May, 2016 were included in the study
and randomized into the study group and the control group with 60 cases in each group. The
patients in the two groups were given cerebral edema alleviating, brain cell protecting, cerebral
circulation improving, and blood pressure controlling. The patients in the study group were
given aspirin enteric-coated tablets, 0.1 g/time, 1 time/d. On the above basis, the patients in
the study group were given ozagrel sodium (80 mg) + 0.9% NaCl (250 mL), ivdrip, 2 times/d.
The patients in the two groups were treated for 14 d. The venous blood was extracted 1 d after
admission and 14 d after treatment. The full automatic biochemical analyzer was used to detect
PLT, PT, TT, FIB, and APTT. The radioimmunoassay was used to detect TXB2 and 6-K-PGF1α.
The color Doppler ultrasound was used to detect IMT. Results: PLT, PT, TT, and APTT after
treatment were not significantly different from those before treatment (P>0.05), but FIB was
significantly reduced, and the reduced degree in the study group was significantly superior to
that in the control group (P<0.05). After treatment, TXB2 level in the two groups was reduced,
while 6-K-PGF1α was elevated, and those in the study group were significantly superior to
those in the control group (P<0.05). After treatment, IMT in the two groups was reduced, and
the reduced degree in the study group was significantly superior to that in the control group
(P<0.05). Conclusions: Aspirin in combined with ozagrel sodium in the treatment of ACI
can effectively inhibit the platelet aggregation, improve the coagulation function and cerebral
blood supply, promote the recovery of cerebral nerve function after infarction, and enhance the
therapeutic effect; therefore, it deserves to be widely recommended in the clinic.
| Reference Key |
2017journalobservation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Hong-Jing Shen ;Hai-Yan He;Ming-Xuan Dai |
| Journal | journal of communications |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.